Mebendazole

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3018 publications

Rapid ultrasensitive detection of levamisole and mebendazole residues in meat products based on an intelligent nanozyme-imprinted fluorescence microfluidic sensor.

Rapid ultrasensitive detection of levamisole and mebendazole residues in meat products based on an intelligent nanozyme-imprinted fluorescence microfluidic sensor.

Journal: Analytical methods : advancing methods and applications

Published: March 27, 2026

Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.

Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.

Journal: Microbiology spectrum

Published: March 17, 2026

Retraction notice to "Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole" [Biomedicine & Pharmacotherapy 167 (2023) 115528].

Retraction notice to "Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole" [Biomedicine & Pharmacotherapy 167 (2023) 115528].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 09, 2026

Thermal and Kinetic Analysis of Benzimidazole Derivatives: Fenbendazole, Mebendazole, and Flubendazole.

Thermal and Kinetic Analysis of Benzimidazole Derivatives: Fenbendazole, Mebendazole, and Flubendazole.

Journal: Molecules (Basel, Switzerland)

Published: February 09, 2026

Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A.

Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A.

Journal: PloS one

Published: January 13, 2026

Evaluation of the Efficacy of Anthelmintic Drugs Against Trichinella spiralis Larvae.

Evaluation of the Efficacy of Anthelmintic Drugs Against Trichinella spiralis Larvae.

Journal: Antibiotics (Basel, Switzerland)

Published: January 07, 2026

Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.

Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.

Journal: Neuro-oncology practice

Published: December 29, 2025

Glycyl-l-histidyl-l-lysine as a novel co-former in co-amorphous systems: Enhanced aqueous solubility and physical stability.

Glycyl-l-histidyl-l-lysine as a novel co-former in co-amorphous systems: Enhanced aqueous solubility and physical stability.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: December 26, 2025

USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer.

USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer.

Journal: Cell death & disease

Published: November 12, 2025

Inhibition of Antioxidant Genes Expression in Echinococcus Granulosus by Baicalein: Implications for Novel Antiparasitic Strategies.

Inhibition of Antioxidant Genes Expression in Echinococcus Granulosus by Baicalein: Implications for Novel Antiparasitic Strategies.

Journal: Acta parasitologica

Published: October 27, 2025

Mebendazole inhibits PELI3-mediated ubiquitination of TRADD in non-small cell lung cancer cells.

Mebendazole inhibits PELI3-mediated ubiquitination of TRADD in non-small cell lung cancer cells.

Journal: Frontiers in oncology

Published: October 23, 2025

Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines.

Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines.

Journal: PloS one

Published: October 22, 2025

Showing 1-12 of 3,018

Last Updated: 04/28/2026